Nyxoah S.A. logo

NYXH Earnings Date: Nov 5, 2026 (Estimated) — Nyxoah S.A.

NASDAQ · Healthcare · Medical Instruments & Supplies

Updated

Price $0.87
Market Cap $90.4M
P/E -0.3
52W Range $0.80 – $5.92
Next Earnings · After close (est.)

When is NYXH's next earnings date?

Nyxoah S.A. (NYXH) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.35 on revenue of $11.0M.

How did NYXH do in its last earnings report?

In its most recent report on Aug 5, 2026 (Q2 2026), Nyxoah S.A. posted EPS of -$0.67 versus the -$0.47 estimate, a miss of 42.5%. Revenue was $8.9M against a $8.6M estimate. The stock's 1-day post-earnings move was -7.1%.

How much does NYXH stock move after earnings?

NYXH beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.1% (up or down) in the day after earnings.

About Nyxoah S.A.

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-05Q2 2026-0.47-0.67-42.55%$8.9M❌ Miss-7.09%+12.06%+24.82%
2026-05-12Q1 2026-0.54-0.43+20.37%$7.5M✅ Beat+0.33%-8.47%-51.47%
2026-03-19Q4 2025-0.65-0.68-4.62%$6.6M❌ Miss-0.32%+0.00%+4.53%
2025-11-13Q3 2025-0.61-0.74-21.31%$2.3M❌ Miss-5.84%-14.31%-7.91%
2025-08-18Q2 2025-0.63-0.62+1.59%$1.5M✅ Beat-4.57%-1.75%-29.07%
2025-03-13Q4 2024-0.47-0.49-4.26%$1.3M❌ Miss+3.29%+13.57%-38.23%
2024-08-06Q2 2024-0.43-0.46-6.98%$830,066❌ Miss+4.50%+1.84%-5.01%
2024-05-14Q1 2024-0.42-0.45-7.14%$1.3M❌ Miss+7.20%+4.38%-16.18%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .